Trials

Open label multicenter Phase I/II study of the safety and efficacy of PDR001 administered to patients with advanced malignancies

Cancer type: Thyroid cancer

Phase: I/II

Principal Investigator: Brunsvig Paal

Country: NO

Keywords: Norway, Oslo, ATC, PDR001, Novartis

Status: Inclusion completed

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02404441?term=CPDR001X2101&rank=1